Myeloperoxidase (MPO) is a lysosomal protein predominantly found in neutrophils, a type of white blood cell instrumental in the body's first line of defense against microbial invaders. MPO is a heme-containing enzyme, and its primary function lies in the catalysis of the conversion of hydrogen peroxide (H2O2) to hypochlorous acid (HOCl) in the presence of chloride ions. This reaction serves a dual purpose: while H2O2 can cause damage to host tissues, its conversion to HOCl generates a potent antimicrobial agent, essential for the neutrophil's bactericidal activity. Given this, MPO plays a pivotal role in the innate immune response, aiding in the rapid neutralization and clearance of pathogens from the body. The significance of MPO extends beyond its enzymatic function, as it also plays a role in modulating inflammatory responses and is involved in the formation of neutrophil extracellular traps, a mechanism by which neutrophils capture and neutralize microbes.
Activators of MPO are molecules or compounds that enhance the expression or enzymatic activity of MPO. These activators may function by upregulating the transcription or translation of the MPO gene, stabilizing the MPO protein structure, or increasing its catalytic efficiency. The presence of MPO activators can amplify the bactericidal capacity of neutrophils, optimizing the efficiency of the innate immune response. Exploring the domain of MPO activators offers a deep dive into the world of neutrophil biology and the intricate molecular mechanisms that underpin immune defense. As the complex dance of cellular immunology continues to be decoded, the role of MPO and its activators emerges as a key chapter, elucidating the molecular strategies that guard against microbial threats.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS stimulates neutrophils and can lead to the release of MPO. It binds to the TLR4 receptor, leading to the activation of NF-κB, which can induce MPO expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), leading to the stimulation of neutrophils and the subsequent release of MPO. | ||||||
GM-CSF | 83869-56-1 | sc-280759 | 5 µg | $516.00 | 1 | |
GM-CSF stimulates the differentiation of progenitor cells into granulocytes and monocytes, which can lead to increased MPO expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can stimulate the release of MPO from neutrophils. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone has been shown to upregulate MPO mRNA levels in certain cell types, potentially leading to increased MPO protein expression. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
This active form of Vitamin D3 can stimulate the differentiation of myeloid cells, potentially leading to increased MPO expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
This compound can stimulate the differentiation of promyelocytic leukemia cells, potentially leading to increased MPO expression. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO can induce differentiation in certain myeloid leukemia cell lines, which may lead to increased MPO expression. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
This agent has been shown to increase MPO expression in some settings, particularly in acute myeloid leukemia. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone can stimulate the differentiation of certain myeloid cells, potentially leading to increased MPO expression. | ||||||